4,6-Octadien-3-ol, 3,7-dimethyl-
Common Name: |
4,6-Octadien-3-ol, 3,7-dimethyl- |
IUPAC Name: |
3,7-dimethylocta-4,6-dien-3-ol |
Molecular Formula: |
C10H18O |
SMILES: |
CCC(C)(C=CC=C(C)C)O |
Inchi: |
1S/C10H18O/c1-5-10(4,11)8-6-7-9(2)3/h6-8,11H,5H2,1-4H3 |
Inchi Key: |
QLRNLHNEZFMRSR-UHFFFAOYSA-N |
Cas No: |
18479-54-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
154.25 |
Mass (g/mol) |
154.136 |
Molar Refractivity |
50.44 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
3 |
Rings |
|
TPSA |
20.23 |
Hetero Atoms |
1 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
222.00 to 223.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.018 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
2.67 |
iLOGP |
2.70 |
XLOGP3 |
2.80 |
WLOGP |
2.67 |
MLOGP |
2.59 |
ESOL Log S |
-2.36 |
ESOL Solubility (mg/ml) |
0.67 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.88 |
Ali Solubility (mg/ml) |
0.2 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.47 |
Silicos-IT Solubility (mg/ml) |
5.21 |
Silicos-IT Solubility (mol/l) |
0.03 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.25 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.59 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.724 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |